Skip Navigation

Research Funding

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

December 21, 2011

Feature Articles

Opportunities and Resources

Other News

Advice Corner

New Funding Opportunities

Header: Feature Articles.

Step Three to a Winning Application: Draft Specific Aims

We moved the contents of this article into Ten Steps to a Winning R01 Application. As part of the Strategy for NIH Funding, the ten steps give you a path to funding success if you're applying for an R01.

Header: Opportunities and Resources.

New NIH Site Helps Companies License Research Materials in Only a Few Days

If your company seeks unpatented materials for internal research and possible commercialization, check out NIH’s new electronic Research Materials catalogue (eRMa).

There you’ll find a list of unpatented NIH intramural research tools—including some developed by NIAID’s scientists—that can be licensed in a few days with a ready-to-go contract and online payment.

Examples include cell lines used to test new therapies, such as NIAID’s norovirus replicon in human (Huh-7).

You can get the materials under a royalty-bearing license agreement with NIH, and you can pay online.

Do you work at an academic or nonprofit organization?

Though you cannot execute a transaction online, you may still find eRMa useful as a catalogue of tools.

If you want to obtain materials, you’ll need a Material Transfer Agreement, not a license. After you search the catalogue and find something you’re interested in, contact Dr. Michael Mowatt in our Office of Technology Development.

Visit the eRMa site to view the catalogue and get more information, including answers to Frequently Asked Questions. NIH will continue to add new items as they come in.

Separator line

RFA Seeks Sites for Expanded Women's HIV Study

A well-established study on HIV in women—the Women's Interagency HIV Study (WIHS)—is expanding.

NIAID and cofunding institutes reissued a request for applications (RFA) last month to introduce WIHS-V.

Changes to the program include broadening the study's reach with a new clinical research site in the southern U.S. and moving to a rolling, rather than closed, cohort design.

The RFA encourages applications from domestic institutions with the capacity to enroll the target population of women who are HIV-positive or HIV-negative but at risk in the southern U.S.—Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, and Texas.

Applications are due February 22, 2012, with optional letters of intent due a month before.

WIHS is a unique global resource as a longitudinal study of predominantly minority women who are not well represented in other clinical studies. It documents comorbidities and is a source of information on highly characterized, rare phenotypes.

The goal of WIHS-V is to continue the clinical, epidemiologic, and basic research that will characterize the long-term, natural and treated history of HIV infection.

By recruiting new women into the cohort and retaining them, it will provide fresh insights into the demographics of the HIV epidemic among U.S. women.

For details on the RFA, read the November 29, 2011, Guide notice. Also see NIAID's WIHS Q&A, which covers administration and oversight, renewal and expansion, and budgeting.

Separator line

Do You Have Your WITS (Specimens) About You?

While we're on the topic of HIV studies, keep in mind you can get access to over 800,000 archived specimens and data from the Women and Infants Transmission Study (WITS).

Completed in 2007, WITS explored the natural history of HIV-1 infection as well as the safety and efficacy of antiretroviral therapy.

It followed over 2,000 HIV-infected pregnant women and their infants, children, and adolescents living in the U.S.

WITS specimens—which are available until the end of 2013—include:

  • Peripheral blood collected in EDTA, ACD, and heparin tubes.
  • Cord blood collected in ACD and heparin tubes.

If you would like access, read the WITS SOP, Access to Archived Specimens and Data from Completed Study: Women and Infants Transmission Study (WITS). Email niaidwitsaccess@mail.nih.gov for more information.

Separator line

Bring an International Collaboration Into Your Grant

Opportunities to get administrative supplements are few and far between, so we'd like to highlight two chances to bolster your funded research with a global health collaboration.

For both the supplements listed below, requests follow a parallel track: you need to meet NIH's requirements, and foreign collaborators must meet their country's requirements. Likewise, your funds will come from NIH, and collaborators will be funded by their government.

Your collaborator can also perform cancer or mental health research if that work fits into the scope of your research.

Start a Russian HIV/AIDS Collaboration

Does your HIV/AIDS research cover basic science, microbicides, vaccines, behavioral and social science research, HIV-related comorbidities, or genomics?

Depending on what type of award you have, you may qualify for a supplement of up to one year to support a collaborative research partnership with a Russian investigator.

Learn more in the October 12, 2011, Guide notice. Send your request by January 15, 2012.

Expand Your Allergy, Immunology, and Infectious Diseases Research to China

You can get up to $100,000 for up to one year to establish or expand collaborative research with Chinese investigators in allergy, immunology, and infectious diseases, including HIV/AIDS and its comorbidities.

For details, including a list of prohibited activities, read the December 2, 2011, Guide notice. Requests are due by February 21, 2012.

Read the Guide notices carefully and make sure to note all steps, such as sending certain information to both NIH and its foreign counterpart: Russian Foundation for Basic Research or Natural Science Foundation of China.

Header: Other News.

More Details on Subaward F&A Costs

We'd like to expand on the answer to our December 7, 2011, reader question "Are facilities and administrative costs for subawards counted as direct costs on my grant?"

Accounting for F&A costs can be complicated. If you have questions, contact your grants management specialist for advice. If you don't know who this is, find one for your region at Grants Management Program Contacts

Before you contact the specialist, you may want to read our advice on how to Get a Speedy Response From Grants Management in our Strategy for NIH Funding.

Separator line

No January AIDS Receipt Date for AREA (R15) Applications

We have news for those of you planning to submit an AIDS or AIDS-related application for the January 7, 2012, Academic Research Enhancement Awards (AREA) receipt date.

Because the AREA program announcement opens January 25 and uses standard receipt dates, NIH does not have any way to accept your application before then. You have to wait for the May 7 receipt date to submit.

We wrote more about the AREA announcement in the November 23, 2011, article "AREA Applicants: Get to Know Your New Parent . . . PA."

Separator line

News Briefs

Here's news from the NIH Guide.

Use the New Sample Interinstitutional Assurance for Animal Research. Starting in January, follow the format of the revised sample Interinstitutional Assurance. You do not have new requirements.

Observe Revised Guidelines on Animal Care and Use. Starting January 1, 2012, your institution and institutional animal care and use committee (IACUC) must follow guidelines in the eighth edition of the Guide for the Care and Use of Laboratory Animals. Read the December 2, 2011, Guide notice for more details.

Upcoming Change of Receipt Date. If you're planning to apply for the standard January 7, 2012, receipt date, take note. That date will roll forward to January 9, 2012, following standard practice when a receipt date falls on a weekend or holiday.

Header: Advice Corner.

Avoid an Identity Crisis

You know who you are. But do we? It's up to you to keep your eRA Commons profile up to date and ensure that you don't have extra accounts.

Check and Update Your Profile

Visit your Commons profile to make sure NIH has correct information. Log in and go to the Personal Profile tab. For detailed steps, see how To Edit Personal Profile Information.

If you're too busy to do this yourself, you can delegate it. Learn how To Delegate Authority to Another User.

Have Too Many Accounts?

It's fine to have multiple accounts due to different roles, such as signing official and PI. But if you have two accounts for the same role, Commons Help Desk staff can merge them to ensure that all your award information and history is properly associated with you.

You may have more than one account if, for example, you had a trainee account and your institution added a regular PI account later. Or perhaps you have two PI accounts from different institutions.

To get accounts consolidated, contact the eRA Commons Help Desk.

Separator line

How to Tell if Your Application Passes Grants.gov

Think of Grants.gov validation as a black box experiment—your application goes into the box, events occur that you can't directly observe, and then typically the application reappears in the Commons.

You can't look inside the black box yourself. Only your institution's business official gets the Grants.gov notifications and status reports.

But you can—and should—keep track of your application's status using what you do know: inputs and outputs.

Input. As you complete the application forms, use the built-in checks to maximize the chances of passing Grants.gov.

Then for the submission stage, keep in close communication with your business office so you know when your application goes to Grants.gov.

Output. You can watch the Commons Status tab to confirm when your application emerges from Grants.gov.

You may also get an email alert from the Commons, but don't rely on that. Learn more at eRA's Steps for PI to Track Submission Status.

Contact your business official right away for any Grants.gov status messages if your application doesn't appear in the Commons within 24 hours after submission or the deadline is drawing near.

For applications that don't pass Grants.gov, you can fix the issues and have your business official submit a corrected application. But your corrected application will be late if it does not pass Grants.gov and get a timestamp by the deadline.

Related Links

 

Header: Reader Questions.

 

Feel free to send us a question at deaweb@niaid.nih.gov. After responding to you, we may include your question in the newsletter, incorporate it into the NIAID Research Funding site, or both.

"If I relocate to another country, can I take my NIH funding with me?"—anonymous reader

Possibly. Though you are allowed to take your funding to a foreign country, you need prior approval from your grants management specialist—including a review by your program officer—plus another approval from NIAID's advisory Council.

You may also need to take other steps depending on your circumstances and the country you wish to move to. 

For your very first step, contact your business office. Your institution must be willing to transfer your grant to a new institution. This move can be complicated, and NIAID is not involved with that decision or any negotiations related to it.

If your institution approves your move, submit a prior approval request to your grants management specialist. Follow the instructions in our Prior Approval for Post-Grant Award Actions SOP.

Header: New Funding Opportunities.

See these and older announcements at NIAID Funding Opportunities List.

back to top


Last Updated March 16, 2012

Last Reviewed December 21, 2011